Global Anatomic Pathology Testing Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Market landscape

• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by products

• Instruments and imaging systems
• Consumables and accessories

PART 07: Market segmentation by application

• Breast cancer
• Lung cancer
• Colorectal cancer
• Lymphoma
• Cervical cancer
• Prostate cancer
• Other diseases

PART 08: Market segmentation by end-user

• Hospitals
• Clinical diagnostic laboratories
• Physicians’ office laboratories

PART 09: Geographical segmentation

• Anatomic pathology testing market in Americas
• Anatomic pathology testing market in EMEA
• Anatomic pathology testing market in APAC

PART 10: Market drivers

• Growing prevalence of cancer in demographics
• Use of biomarkers for disease diagnosis and increasing efficiency
• Paradigm shift toward precision diagnosis through personalized medicine

PART 11: Impact of drivers

PART 12: Market challenges

• Insurance coverage and reimbursement issues
• Limitations of closed systems
• High initial investment and maintenance cost

PART 13: Impact of drivers and challenges

PART 14: Market trends

• Presence of venture capitalists in market
• Ready-to-use reagents
• Business strategies to increase market competitiveness

PART 15: Vendor landscape

• Competitive landscape analysis

PART 16: Key vendor analysis

• Abbott Diagnostics
• Agilent Technologies
• Danaher
• Roche Diagnostics
• Thermo Fisher Scientific
• Other prominent vendors

PART 17: Appendix

• List of abbreviations

PART 18: Explore Technavio